Management of Continuous Hiccups
For intractable hiccups, initiate chlorpromazine 25-50 mg orally three to four times daily as first-line pharmacotherapy, as it remains the only FDA-approved medication for this indication. 1
Initial Assessment and Reversible Causes
Before initiating pharmacotherapy, identify and address potentially serious underlying etiologies:
- Screen for central nervous system pathology including brain tumors, traumatic brain injury, or stroke, which can directly trigger the hiccup reflex arc 2
- Evaluate for pericardial effusion if the patient has chest symptoms, as compression of the phrenic nerve can cause persistent hiccups; obtain chest X-ray and echocardiography if suspected 2
- Consider gastroesophageal reflux disease (GERD) as a common peripheral cause and initiate high-dose proton pump inhibitor (PPI) therapy empirically, with response potentially taking 2 weeks to several months 2
- Implement antireflux diet and lifestyle modifications concurrently with PPI therapy 2
Pharmacological Management Algorithm
First-Line: Chlorpromazine
Chlorpromazine is the gold standard and only FDA-approved treatment for intractable hiccups:
- Oral dosing: 25-50 mg three to four times daily 1
- If symptoms persist after 2-3 days of oral therapy: Give 25-50 mg intramuscularly, or use slow IV infusion (25-50 mg in 500-1000 mL saline) with the patient flat in bed and close blood pressure monitoring 3
- Critical warnings: Monitor for hypotension, sedation, extrapyramidal symptoms, and QT interval prolongation 2
Second-Line: Metoclopramide
If chlorpromazine is contraindicated or ineffective, metoclopramide is recommended as second-line therapy:
- Particularly effective for peripheral causes of hiccups, including GERD-related cases 2, 4
- Can be added to PPI therapy if partial or no improvement occurs with acid suppression alone 2
- Recommended by the American Society of Clinical Oncology based on randomized controlled trial evidence 2
Third-Line: Baclofen
For central causes of persistent hiccups (CNS pathology), baclofen is the preferred agent:
- A gamma-aminobutyric acid (GABA) analog that acts on the central hiccup reflex arc 5, 4
- Particularly useful when central nervous system lesions are identified 4
Alternative Agents
Additional pharmacological options when standard therapies fail:
- Gabapentin - acts on the reflex arc 6
- Midazolam - may be useful specifically in terminal illness cases 4
- Serotonergic agonists, lidocaine - alternative options with limited evidence 6
Non-Pharmacological Interventions
Physical Maneuvers (First Attempt)
Simple measures that stimulate the uvula/pharynx or disrupt diaphragmatic rhythm should be tried initially:
Interventional Procedures (Refractory Cases)
For patients who fail pharmacotherapy, consider:
Critical Clinical Pitfalls
- Do not delay treatment: Untreated persistent hiccups can lead to weight loss and depression, significantly impacting quality of life 2
- Monitor for hypotension with chlorpromazine: Elderly patients are particularly susceptible; use lower initial doses and observe closely 1, 3
- Avoid subcutaneous chlorpromazine injection: Use deep intramuscular injection in the upper outer quadrant of the buttock only 3
- Never inject undiluted chlorpromazine into a vein: IV route is reserved only for severe hiccups, surgery, and tetanus, and must be diluted to at least 1 mg/mL 3
- Consider 24-hour esophageal pH monitoring if empiric GERD therapy is unsuccessful after adequate trial 2